Latest Asx Listing News

Greatland Resources Limited has reported a robust unaudited FY2025 result, generating $337.3 million net profit after tax from seven months of Telfer gold-copper mine operations, alongside a successful ASX listing and strong cash flow.

Invion Limited has affirmed its compliance with ASX disclosure rules following the US FDA’s granting of Orphan Drug Designation for its anal cancer treatment candidate INV043. The company detailed the timing and verification process behind its announcement.

Pengana Capital Group reported a strong turnaround in FY 2025 profitability, driven by a surge in private credit funds under management and successful new product launches. The firm’s strategic shift towards private markets is reshaping its revenue profile and balance sheet strength.

Diatreme Resources has agreed to sell its Clermont Gold Project to Moonlight Resources as part of Moonlight’s upcoming ASX IPO, securing a significant equity stake and board representation.

Eagers Automotive Limited has announced a fully franked interim dividend of AUD 0.24 per share for the half-year ending June 2025, signaling steady returns for shareholders.

Moonlight Resources, partly owned by Lithium Plus Minerals, plans to acquire the Clermont Gold Project and pursue an ASX listing, aiming to become a focused gold and critical minerals explorer.

Urbanise.com Limited reported a 4.2% revenue increase to $13.1 million in FY2025, alongside a landmark strategic partnership with National Australia Bank that promises to disrupt the strata management industry’s legacy banking model.

InvestSMART Group has showcased its position as Australia’s leading direct-to-investor digital wealth platform, reporting $711 million in funds under management and highlighting its integrated ecosystem of low-cost funds, research, and tools.

James Hardie Industries confirms its Q1 FY26 earnings met market expectations despite a challenging North American housing market, while revising its FY26 guidance following the AZEK acquisition.

AXP Energy has updated its resource disclosures and is accelerating its gas-to-power strategy to fuel bitcoin mining operations in Oklahoma, leveraging proven oil fields and strong industry partnerships.

Cambium Bio has updated its placement, raising A$2.17 million to fund late-stage clinical trials for its lead ophthalmology product, Elate Ocular®. The capital raise reflects strong investor interest and strategic backing.

Pengana International Equities has acknowledged breaching ASX disclosure rules by sharing details of a new private credit strategy with media before official announcement, prompting a policy overhaul.